Previsioni di mercato degli agenti di embolizzazione per l\'Asia Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotto (bobine, tappi, perline/particelle, palloncini staccabili, colla, spugne, emboli liquidi, sclerosanti, agenti precipitanti e altri), applicazione (oncologia, Neurologia, Urologia, Cardiologia, Malattie vascolari periferiche e altri) e Utente finale (ospedali, centri cardiaci, centri chirurgici ambulatoriali e altri)

Introduzione al mercato

Il mercato degli agenti di embolizzazione dell\'APAC viene analizzato sulla base dei cinque principali paesi come come Cina, Giappone, India, Australia, Corea del Sud e il resto dell’APAC. Si prevede che la crescita del mercato nella regione APAC crescerà a un ritmo più rapido a causa di fattori quali la crescente prevalenza di ictus cerebrale, malattie delle arterie coronarie, malattie cardiache, aumento delle procedure chirurgiche, numero crescente di ospedali e centri di chirurgia ambulatoriale, concentrazione da parte degli operatori del settore in Giappone e lo sviluppo delle infrastrutture sanitarie in India probabilmente stimoleranno la crescita del mercato nel periodo di previsione. Secondo la World Herat Federation, si stima che le malattie non trasmissibili, comprese le malattie cardiovascolari, rappresentino l’87% del totale dei decessi adulti in Cina. La Cina ha uno dei tassi di mortalità per malattie cardiovascolari più alti al mondo. Il peso delle malattie cardiovascolari aumenta in modo significativo a causa dell’alta pressione sanguigna; anche altri fattori, come l’elevata prevalenza del fumo e una dieta non sana, hanno contribuito all’aumento dell’incidenza delle malattie cardiovascolari. Ci sono più di 300 milioni di fumatori nel paese. Poiché la popolazione invecchia a un ritmo sempre più rapido, si prevede che il numero di pazienti affetti da malattie croniche aumenterà. L’incidenza di ictus è aumentata negli ultimi anni e l’incidenza di aneurisma dell’aorta addominale è aumentata nel Paese, spingendo all’adozione di agenti di embolizzazione nel periodo di previsione. Detto questo, il governo cinese ha investito maggiormente nella prevenzione e nel trattamento delle malattie non trasmissibili. Inoltre, le tecniche avanzate per la prevenzione e le procedure di trattamento dell’ictus hanno facilitato la standardizzazione della cura dell’ictus da parte dei medici e migliorato le loro competenze in tutto il Paese. Inoltre, la solida infrastruttura sanitaria del paese sta facilitando l’adozione di tecnologie avanzate. Ad esempio, quasi il 7,4% dei 124 ospedali hanno istituito unità di ictus a Pechino. Inoltre, in tutto il Paese sono state installate circa 300 unità di corsa, determinando la crescita del mercato. Inoltre, in Cina, per soddisfare le esigenze sanitarie della popolazione, il paese ha sviluppato Healthy China 2030. Inoltre, gli operatori del mercato sono impegnati in attività strategiche per espandere la propria presenza sul mercato. Ad esempio, nel maggio 2021, Grand Pharmaceutical and Healthcare Holdings Limited ha acquisito i diritti sull\'innovativo agente embolico termosensibile di Shenming Medical Technology Co., Ltd. per il trattamento del cancro al fegato, espandendo ulteriormente la pipeline di prodotti per il trattamento dell\'intervento tumorale. Pertanto, a causa dei fattori sopra menzionati, il mercato degli agenti di embolizzazione crescerà in modo significativo nel periodo di previsione

La pandemia di COVID-19 ha portato a un calo delle procedure cardiache in Paesi dell’Asia Pacifico. Ad esempio, il numero di interventi cardiaci eseguiti tra aprile e luglio presso l’All-India Institute of Medical Sciences (AIIMS) è diminuito dell’89,5%. Allo stesso modo, anche l’Australia ha registrato una riduzione degli interventi cardiaci. Lo studio riportato in Heart, Lung & La circolazione ha mostrato che da marzo a giugno 2020, 136 adulti sono stati sottoposti a intervento di chirurgia cardiaca, il che rappresenta un calo del 21% del numero di casi operatori in Australia. L’ulteriore epidemia ha colpito gravemente il settore del turismo medico nell’Asia del Pacifico e ha imposto interruzioni della catena di approvvigionamento; inoltre, i paesi a basso reddito si trovano ad affrontare ulteriori sfide dovute al sottosviluppo delle infrastrutture sanitarie nei paesi in via di sviluppo, alle restrizioni imposte ai fornitori dagli ospedali, alla diminuzione della domanda di strumenti chirurgici cardiovascolari, ecc. Misure restrittive sono state adottate in Corea del Sud, Malesia, Singapore, Filippine e India per prevenire la trasmissione di malattie, che stanno incidendo sulle catene di approvvigionamento e sulla disponibilità dei dispositivi medici in questi paesi. Hanno avuto ripercussioni anche sui redditi disponibili e hanno provocato disoccupazione. Inoltre, le strategie aziendali come acquisizioni, fusioni e partnership sono influenzate negativamente dall’imposizione del blocco completo. Tuttavia, si prevede che l\'aumento del ritmo delle iniziative di vaccinazione e la disponibilità di politiche di rimborso governative per varie procedure cardiovascolari normalizzeranno la situazione nell\'Asia del Pacifico e aumenteranno gradualmente la domanda di prodotti di embolizzazione nei prossimi anni.

Panoramica e dinamiche del mercato

Il mercato degli agenti di embolizzazione in Si prevede che l’Asia Pacifico crescerà da 585,86 milioni di dollari nel 2021 a 1.022,36 milioni di dollari entro il 2028; si stima che crescerà a un CAGR dell\'8,3% dal 2021 al 2028. Aumento dell\'incidenza di ipertensione, obesità, fumo e alcolismo; ipertensione, fumo, alcolismo e obesità sono associati allo sviluppo di aneurismi cerebrali. Pertanto, è probabile che la crescente prevalenza di queste malattie alimenterà la domanda di mercato degli agenti di embolizzazione. Il cancro del rene sta diventando sempre più comune nelle persone di ogni età, razza e dimensione del tumore. L\'ipertensione, il sovrappeso e il fumo sono tutti fattori di rischio per il cancro del rene. L\'obesità è associata a pressione alta, dislipidemia, diabete o resistenza all\'insulina, nonché a livelli più elevati di fibrinogeno e di proteina C-reattiva, che aumentano il rischio di cancro al rene. rischio di eventi di malattie cardiovascolari (CVD). L’obesità è stata associata a un rischio più elevato di ipertensione arteriosa, oltre a malattie cardiovascolari. Gli agenti embolizzanti come l\'Amplatzer Vascular Plug (AVP) sono stati creati per l\'embolizzazione periferica come modifica della famiglia di occlusori settali Amplatz utilizzati nel trattamento delle malformazioni cardiache congenite. Pertanto, la crescente prevalenza di ipertensione, fumo, alcolismo e obesità che richiedono assistenza per la mobilità favorirà probabilmente la crescita del mercato degli agenti di embolizzazione nell\'area APAC.

Segmenti chiave del mercato

In base al prodotto, il mercato è segmentato in bobine, perline/particelle, tappi, palloncini staccabili, colla, spugna, embolici liquidi, sclerosanti, agenti precipitanti, altri. Il segmento perle/particelle ha detenuto la quota maggiore del mercato nel 2020. In base alle bobine, il mercato è suddiviso in bobine rimovibili e bobine spingebili. Il segmento delle bobine spingebili ha detenuto la quota maggiore del mercato nel 2020. In base alle perle/particelle il mercato è suddiviso in sferiche e non sferiche. Il segmento non sferico spingebile deteneva la quota maggiore del mercato nel 2020. In base all\'applicazione, il mercato è segmentato in neurologia, oncologia, cardiologia, malattie vascolari periferiche e altri. Nel 2020, il segmento oncologico deterrà probabilmente la quota maggiore del mercato. Il mercato degli agenti di embolizzazione per utente finale è segmentato in ospedali, centri chirurgici ambulatoriali, centri cardiaci e altri. Il segmento ospedaliero ha detenuto la quota maggiore del mercato nel 2020.

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato degli agenti di embolizzazione nell\'Asia del Pacifico sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra cui altri. Le principali società elencate nel rapporto sono Abbott; Società scientifica di Boston; Cook Medical LLC; DePuy sintetizza; CORPORAZIONE KANEKA; Medtronic; Merito Medical Systems Inc; Penombra, Inc.; Stryker Corporation; e Terumo Corporation, tra gli altri.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato degli agenti di embolizzazione nell\'Asia del Pacifico e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
Stai al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato degli agenti di embolizzazione dell\'Asia Pacifico
Pianifica in modo efficiente fusioni e acquisizioni e accordi di partnership nel mercato degli agenti di embolizzazione dell\'Asia Pacifico identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi perspicace e completa delle prestazioni di mercato dei vari segmenti dal mercato degli agenti di embolizzazione dell\'Asia del Pacifico
Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione dell\'Asia del Pacifico.

SEGMENTAZIONE DEL MERCATO DEGLI AGENTI EMBOLIZZATORI DELL\'ASIA PACIFICO

Per prodotto

Bobine
Bobine rimovibili
Bobine spingibili
Perline/Particelle
Sferica
Non sferici
Tappi
Palloncini staccabili
Colla
Spugna
Embolia liquida
Sclerosanti
Agenti precipitanti
Altri

Da Applicazione

Per Utente finale

Ospedali
Centri cardiaci
Centri chirurgici ambulatoriali
Altri

Per Paese

Cina
Giappone

India
Australia
Corea del Sud
< span>Resto dell\'Asia Pacifico

Profili aziendali

1.           Introduction
1.1       Scope of the Study
1.2       The Insight Partners Research Report Guidance
1.3       Market Segmentation
1.3.1        APAC Embolization Agents Market – By Product
1.3.2        APAC Embolization Agents Market – By Application
1.3.3        APAC Embolization Agents Market – By End User
1.3.4        APAC Embolization Agents Market – By Country
2.           APAC Embolization Agents Market – Key Takeaways
3.       Research Methodology
3.1       Coverage
3.2       Secondary Research
3.3       Primary Research
4.           APAC Embolization Agents Market – Market Landscape
4.1       Overview
4.2       PEST Analysis
4.2.1        APAC – PEST Analysis
4.3       Experts Opinion
5.           APAC Embolization Agents Market– Key Market Dynamics
5.1       Market Drivers
5.1.1        Increasing Incidence of Tumors and Aneurysms
5.1.1        Surge in Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2       Market Restraints
5.2.1        High Cost of Embolization Agents
5.3       Market Opportunities
5.3.1        Growing Geriatric Population Base
5.4       Future Trends
5.4.1        Technological Advancements in Embolization Products and Procedures
5.5       Impact analysis
6.           Embolization Agents Market – APAC Analysis
6.1       APAC Embolization Agents Market Revenue Forecast and Analysis
7.           APAC Embolization Agents Market Analysis – By Product
7.1       Overview
7.2       APAC Embolization Agents Market Revenue Share, by Product (2021 and 2028)
7.3       Coils
7.3.1        Overview
7.3.2        Coils: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1      Detachable Coils
7.3.2.1.1       Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2       Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2      Pushable Coils
7.3.2.2.1       Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2       Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4       Beads/Particles
7.4.1        Overview
7.4.2        Beads/Particles: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1      Spherical
7.4.2.1.1       Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2       Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2      Non-Spherical
7.4.2.2.1       Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2       Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5       Plugs
7.5.1        Overview
7.5.2        Plugs: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6       Detachable Balloons
7.6.1        Overview
7.6.2        Detachable Balloons: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7       Glue
7.7.1        Overview
7.7.2        Glue: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8       Sponge
7.8.1        Overview
7.8.2        Sponge: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9       Liquid Embolics
7.9.1        Overview
7.9.2        Liquid Embolics: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10    Sclerosants
7.10.1     Overview
7.10.2     Sclerosants: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11    Precipitating Agents
7.11.1     Overview
7.11.2     Precipitating Agents: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12    Others
7.12.1     Overview
7.12.2     Others: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8.           APAC Embolization Agents Market Analysis – By Application
8.1       Overview
8.2       APAC Embolization Agents Market, by Application 2021 & 2028 (%)
8.3       Oncology
8.3.1        Overview
8.3.2        Oncology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4       Neurology
8.4.1        Overview
8.4.2        Neurology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5       Urology
8.5.1        Overview
8.5.2        Urology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6       Cardiology
8.6.1        Overview
8.6.2        Cardiology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7       Peripheral Vascular Diseases
8.7.1        Overview
8.7.2        Peripheral Vascular Diseases: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8       Others
8.8.1        Overview
8.8.2        Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.           APAC Embolization Agents Market Analysis – By End User
9.1       Overview
9.2       APAC Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3       Hospitals
9.3.1        Overview
9.3.2        Hospitals: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4       Cardiac Centers
9.4.1        Overview
9.4.2        Cardiac Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5       Ambulatory Surgical Centers
9.5.1        Overview
9.5.2        Ambulatory Surgical Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6       Others
9.6.1        Overview
9.6.2        Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10.        APAC Embolization Agents Market – Country Analysis
10.1    APAC: Embolization Agents Market
10.1.1     Overview
10.1.2     APAC: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1    China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1    China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2    China: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.1.2.1.2.1        China: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.1.2.1.2.2        China: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.1.2.1.3    China: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.1.2.1.4    China: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.1.2.2    Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1    Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2    Japan: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.1.2.2.2.1        Japan: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.2.2.2        Japan: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.1.2.2.3    Japan: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.1.2.2.4    Japan: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.1.2.3    India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1    India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2    India: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.1.2.3.2.1        India: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.1.2.3.2.2        India: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.1.2.3.3    India: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.1.2.3.4    India: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.1.2.4    Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1    Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2    Australia: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.1.2.4.2.1        Australia: Embolization Agents Market, By Coil, 2019–2028 (USD Million)
10.1.2.4.2.2        Australia: Embolization Agents Market, By Beads/ Particles, 2019–2028 (USD Million)
10.1.2.4.3    Australia: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.1.2.4.4    Australia: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.1.2.5    South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.1    South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.2    South Korea: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.1.2.5.2.1        South Korea: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.5.2.2        South Korea: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.1.2.5.3    South Korea: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.1.2.5.4    South Korea: Embolization Agents Market, by End User, 2019–2028 (USD Million)
10.1.2.6    Rest of APAC: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.1    Rest of APAC: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2    Rest of APAC: Embolization Agents Market, by Product, 2019–2028 (USD Million)
10.1.2.6.2.1        Rest of APAC: Embolization Agents Market, by Coil, 2019–2028 (USD Million)
10.1.2.6.2.2        Rest of APAC: Embolization Agents Market, by Beads/ Particles, 2019–2028 (USD Million)
10.1.2.6.3    Rest of APAC: Embolization Agents Market, By Application, 2019–2028 (USD Million)
10.1.2.6.4    Rest of APAC: Embolization Agents Market, by End User, 2019–2028 (USD Million)
11.        Impact Of COVID-19 Pandemic on APAC Embolization Agents Market
11.1    APAC: Impact Assessment of COVID-19 Pandemic
12.        APAC Embolization Agents Market–Industry Landscape
12.1    Overview
12.2    Organic Developments
12.2.1     Overview
12.3    Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1    Medtronic
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2    Terumo Corporation
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3    Cook Medical LLC
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4    Boston Scientific Corporation
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5    Abbott
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6    Stryker Corporation
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7    Penumbra, Inc.
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8    Merit Medical Systems Inc.
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9    DePuy Synthes
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
13.10 KANEKA CORPORATION
13.10.1   Key Facts
13.10.2   Business Description
13.10.3   Products and Services
13.10.4   Financial Overview
13.10.5   SWOT Analysis
13.10.6   Key Developments
14.        Appendix
14.1    About The Insight Partners
14.2    Glossary of Terms

LIST OF TABLES
Table 1.             APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2.             China: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3.             China: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 4.             China: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 5.             China: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 6.             China: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 7.             Japan: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 8.             Japan: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 9.             Japan: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 10.          Japan: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 11.          Japan: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 12.          India: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 13.          India: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 14.          India: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15.          India: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16.          India: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17.          Australia: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 18.          Australia: Embolization Agents Market, By Coil – Revenue and Forecast to 2028 (USD Million)
Table 19.          Australia: Embolization Agents Market, By Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 20.          Australia: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 21.          Australia: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 22.          South Korea: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 23.          South Korea: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 24.          South Korea: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 25.          South Korea: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 26.          South Korea: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 27.          Rest of APAC: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 28.          Rest of APAC: Embolization Agents Market, by Coil – Revenue and Forecast to 2028 (USD Million)
Table 29.          Rest of APAC: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 30.          Rest of APAC: Embolization Agents Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 31.          Rest of APAC: Embolization Agents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 32.          Organic Developments Done by Companies
Table 33.          Inorganic Developments Done by Companies
Table 34.          Glossary of Terms, APAC Embolization Agents Market

LIST OF FIGURES
Figure 1.           APAC Embolization Agents Market Segmentation
Figure 2.           APAC Embolization Agents Market Segmentation, By Country
Figure 3.           APAC Embolization Agents Market Overview
Figure 4.           Beads/ Particles Segment Held the Largest Share of the Product Segment in APAC Embolization Agents Market
Figure 5.           India to Show Significant Growth During Forecast Period
Figure 6.           APAC PEST Analysis
Figure 7.           APAC Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8.           APAC Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9.           APAC Embolization Agents Market Revenue Share, by Product (2021 and 2028)
Figure 10.        Coils: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11.        Beads/Particles: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Plugs: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Detachable Balloons: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14.        Glue: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15.        Sponge: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16.        Liquid Embolics: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17.        Sclerosants: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18.        Precipitating Agents: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19.        Others: APAC Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20.        APAC Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21.        Oncology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22.        Neurology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23.        Urology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24.        Cardiology: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        Peripheral Vascular Diseases: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        APAC Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28.        Hospitals: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29.        Cardiac Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30.        Ambulatory Surgical Centers: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31.        Others: APAC Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32.        APAC: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 33.        APAC: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34.        China: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 35.        Japan: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 36.        India: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 37.        Australia: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 38.        South Korea: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 39.        Rest of APAC: Embolization Agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 40.        Impact of COVID-19 Pandemic in APAC Country Markets

Abbott
Boston Scientific Corporation
Cook Medical LLC
DePuy Synthes
KANEKA CORPORATION
Medtronic
Merit Medical Systems Inc
Penumbra, Inc.
Stryker Corporation
Terumo Corporation

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific Embolization Agents Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022

Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022

Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.